E
S. M. Mennen et al.
Letter
Synlett
processing from step 2 to step 5 by incorporation of a final
distillation to purify the desired bicyclic ketone 6. Lastly, we
have identified Dess–Martin periodinane as an alternative
to using the carcinogenic CrO3 as the final oxidant.
mixture was then diluted with water (20,000 mL, 20 V) and
extracted twice with PE (12,000 mL, 12 V). The combined
organic extracts were washed twice with 5% w/w Na2S2O3 solu-
tion (10,000 L, 10 V), dried over anhydrous Na2CO4, and concen-
trated under vacuum at 35 °C to get the crude product.
The crude product was dissolved in hexane (4,000 mL, 4 V),
cooled to –40 °C, and stirred for 30 min. The solid was filtered,
washed with chilled hexane (1,000 mL, 1 V), and dried at 25 °C
for 5 h to get 850 g of (1S,3R,4R,6R)-4-bromo-3,7,7-trimethylbi-
cyclo[4.1.0]heptan-3-ol as off-white solid as main crop with
95% GC purity. The mother liquor was cooled to –40 °C, stirred
for 30 min, filtered, dried, and isolated another 100 g as off-
white solid (second crop) with 94% purity by GC. Both the crops
material were mixed and taken forward into the next step. TLC:
PE/EtOAc (8:2); Stain solution: PMA (10% EtOH), yield 950 g
(56%). 1HNMR of first crop (300 MHz, CDCl3): δ = 0.69 (t, J = 7.26
Hz, 1 H), 0.80–0.88 (m, 1 H), 0.99 and 1.02 (s, 6 H), 1.30 (s, 3 H),
1.41 (d, J = 4.92 Hz, 1 H), 2.20 (dd, J = 14.63 and 9.72 Hz, 1 H),
2.34–2.49 (m, 2 H), 4.06 (dd, J = 10.79 and 7.95 Hz, 1 H).
(12) Current costs from sigmaaldrich.com of 99% purity silver salt:
AgNO3(S6506-500G at $1,071.20/0.5kg) costs $546/mol 3 using
1.5 equiv AgNO3 and Ag2O (item: 221163-1KG at $2,195.00/kg)
costs $1,017/mol 3 using 2.0 equiv Ag2O.
(13) (a) Harding, K. E.; Trotter, J. W. J. Org. Chem. 1977, 42, 4157.
(b) Harding, K. E.; Strickland, J. B.; Pommerville, J. J. Org. Chem.
1988, 53, 4877.
(14) For examples of AgNO3-mediated ring expansion, see:
(a) Pauvert, M.; Dupont, V.; Guingant, A. Synlett 2002, 1350.
(b) Morimoto, T.; Yamazaki, A.; Achiwa, K. Chem. Pharm. Bull.
2004, 52, 1367.
(15) Throughout the investigation, an unidentified impurity was
present at 0.95 RRT. The impurity had the same nominal mass
by low resolution GC–MS as the desired product 3. The impurity
was present in varying amounts and is hypothesized to be the
result of either elimination of HBr or epoxidation.
(16) Distillation conditions: Batch temperature 54–56 °C, pressure
5–2 mbar, isolated yield 85% on 10 g scale. Equipment: Short
path distillation head with a combined cold-coil and Liebig con-
denser and affixed with a three-port distribution adapter.
(17) Distillation conditions: batch temperature 85–105 °C, pressure
10–1 mbar, isolated yield 88% on 7 g scale. Equipment: Short
path distillation head with a combined cold-coil and Liebig con-
denser and affixed with a three-port distribution adapter.
(18) International Conference on Harmonization (2014). M7(R4):
Assessment and Control of DNA Reactive (Mutagenic) Impuri-
ties in Pharmaceuticals to Limit Potential Carcinogenic Risk.
(19) (a) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155. (b) Dess,
D. B.; Martin, J. C. J. Am. Chem. Soc. 1991, 113, 7277.
(c) Boeckman, R. K.; Shao, S.; Mullins, J. J. Org. Synth. 2000, 77,
141.
Acknowledgment
We thank Karunanidhi S. and Balaji D. for analytical method develop-
ment and Dr. Jason Tedrow, Amgen Inc.; Andreas Reichelt, Amgen Inc.,
and Dr. Jegadeesh T, Syngene Intl. Ltd for their constant support
throughout this collaboration.
Supporting Information
Supporting information for this article is available online at
S
u
p
p
ortiInfogrmoaitn
S
u
p
p
ortioInfgrmoaitn
References and Notes
(1) Bolli, M.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.;
Velker, J.; Weller, T. WO 2006100635A2, 2006.
(2) Edwards, M. G.; Paxton, R. J.; Pugh, D. S.; Whitwood, A. C.;
Taylor, R. J. K. Synthesis 2008, 3279.
(3) Charette, A.; Wilb, N. Synlett 2002, 176.
(4) (a) Fürstner, A.; Hannen, P. Chem. Eur. J. 2006, 12, 3006.
(b) Blaszykowski, C.; Harrak, H.; Brancour, C.; Nakama, K.;
Dhimane, A.-L.; Fensterbank, L.; Malacria, M. Synthesis 2007,
2037.
(5) Rigby, J. H.; Bellemin, A. Synthesis 1988, 188.
(6) Bolli, M.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.;
Velker, J.; Weller, T. WO 2006100635A2, 2006.
(7) (a) Kuczyński, H.; Walkowicz, M.; Walkowicz, C.; Nowak, K.;
Siemion, I. Z. Rocz. Chem. 1964, 38, 1625. (b) Walkowicz, M.;
Kuczyński, H.; Walkowicz, C. Rocz. Chem. 1967, 41, 927. Bromo-
hydrin synthesis: (c) Crocker, W.; Grayson, D. H. Tetrahedron
Lett. 1969, 51, 4451. Synthesis of ketone from alcohol (post pin-
acol): (d) Lochyński, S.; Jarosz, B.; Walkowicz, M.; Piatkowski, K.
J. Prakt. Chemie. 1988, 284.
(8) Current costs from sigmaaldrich.com (Item: 94415-1ML at
$54.10; Item: W382108-1KG at $97).
(9) See Supporting Information for GC method details.
(10) Unidentified impurity was present at a relative retention time
(RRT) of 0.87 min by gas chromatography.
(11) (1S,3R,4R,6R)-4-Bromo-3,7,7-trimethylbicyclo[4.1.0]heptan-
3-ol (2)
To a clean and dry 45 L glass reactor was charged 1,4-dioxane
(8,000 mL, 8.0 V), water (4,000 mL, 4.0 V), (+)-3-carene (1,000 g,
7.3 mol), and CaCO3 (977 g, 9.8 mol), and the suspension was
cooled to 10 °C. NBS (1,698 g, 9.5 mol) was added in portions
over 1 h while maintaining the internal temperature. At the end
of addition, the resulting mixture was warmed to 20 °C and
maintained for 3 h, and the progress of the reaction was moni-
tored by GC until (+)-3-carene was not detected. The reaction
(20) (a) Plumb, J. B.; Harper, D. J. Chem. Eng. News. 1990 July 16, 3.
(b) Uyanik, M.; Ishihara, K. Aldrichimica Acta 2010, 43, 83.
(c) Boeckman, R. K.; Shao, S. Mullins J. 2000, 77, 141.
(21) Bercot, E. A.; Bio, M.; Chan, J.; Colyer, J.; Fang, Y.; Mennen, S.;
Milburn, R. R.; Tedrow, J.; Riahi, B. WO 2013173672, 2013.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2017, 28, A–E